Ryan Hutto is Head of Commercial Diagnostics at Pfizer Oncology. He has designed and built commercial diagnostics capabilities across Pfizer’s oncology portfolio, connecting diagnostic strategy with laboratory testing, clinical workflows, and patient identification to help make biomarker results actionable in care.
Ryan has held leadership roles across biotechnology and pharmaceuticals, with experience in internal medicine, medical devices, laboratory diagnostics, rare diseases, and oncology. His oncology work spans hematologic malignancies and solid tumors, and his career includes experience across U.S. and global markets. Previously, Ryan led commercial diagnostics at Seagen, where he built its Commercial Diagnostics Center of Excellence. He also held roles at Alexion, Labcorp, and Sanofi.
Ryan brings to PMC a practical perspective on closing the gap between diagnostic innovation and its use in clinical care.